Venous Thromboembolism: An Unrecognized Crisis in Gynecologic Oncology
- PMID: 28937561
- DOI: 10.1097/AOG.0000000000002305
Venous Thromboembolism: An Unrecognized Crisis in Gynecologic Oncology
Comment in
-
In Reply.Obstet Gynecol. 2017 Oct;130(4):914-915. doi: 10.1097/AOG.0000000000002304. Obstet Gynecol. 2017. PMID: 28937562 No abstract available.
References
-
- Jarrett PE, Morland M, Browse NL. Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement. Br Med J 1977;1:933–4.
-
- Small M, McArdle MB, Lowe GD, Forbes CD, Prentice CR. The effect of intramuscular stanozolol on fibrinolysis and blood lipids. Thomb Res 1982;28:27–36.
-
- Menon IS. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction). Acta Univ Carol Med Monogr 1972;52:19–23.
-
- Bielawiec M, Myśliwiec M, Perzanowski A. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis. Folia Haematol Int Mag Klin Morphol Blutforsch 1974;101:483–8.
-
- Kluft C, Bertina RM, Preston FE, Malia RG, Blamey SL, Lowe GD, et al. Protein-C, an anticoagulant protein is increased in healthy volunteers and surgical patients after treatment with stanozolol. Thromb Res 1984;33:297–304.
LinkOut - more resources
Full Text Sources
Other Literature Sources